Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 24;14(17):1849.
doi: 10.3390/diagnostics14171849.

Relapse Predictors in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

Katarzyna Wawrzycka-Adamczyk  1 , Mariusz Korkosz  1   2 , Jacek Musiał  2 , Krzysztof Wójcik  1   2
Affiliations
Review

Relapse Predictors in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis

Katarzyna Wawrzycka-Adamczyk et al. Diagnostics (Basel). .

Abstract

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a group of rare diseases with a chronic and relapsing course. Recent treatment guidelines offer many therapeutic options depending mainly on the type of diagnosis and disease manifestations. Areas that remain under discussion include whether all patients diagnosed with AAV belong to a homogeneous group with a similar prognosis at baseline or if the type and duration of remission-inducing treatment should depend on factors other than just diagnosis and disease severity. The aim of this review is to present the recent literature on the tools available to use while evaluating the risk of relapse in patients upon presentation as well as potential biomarkers of proceeding flare in patients upon remission.

Keywords: predictors; relapse; vasculitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

Cited by

References

    1. Gonzalez-Gay M.A., Garcia-Porrua C., Guerrero J., Rodriguez-Ledo P., Llorca J. The Epidemiology of the Primary Systemic Vasculitides in Northwest Spain: Implications of the Chapel Hill Consensus Conference Definitions. Arthritis Rheum. 2003;49:388–393. doi: 10.1002/art.11115. - DOI - PubMed
    1. Watts R.A., Lane S.E., Bentham G., Scott D.G. Epidemiology of Systemic Vasculitis: A Ten-Year Study in the United Kingdom. Arthritis Rheum. 2000;43:414–419. doi: 10.1002/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0. - DOI - PubMed
    1. Mohammad A.J., Jacobsson L.T., Westman K.W., Sturfelt G., Segelmark M. Incidence and Survival Rates in Wegener’s Granulomatosis, Microscopic Polyangiitis, Churg-Strauss Syndrome, and Polyarteritis Nodosa. Rheumatology. 2009;48:1560–1565. doi: 10.1093/rheumatology/kep304. - DOI - PubMed
    1. Jennette J.C., Falk R.J., Bacon P.A., Basu N., Cid M.C., Ferrario F., Flores-Suarez L.F., Gross W.L., Guillevin L., Hagen E.C., et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1–11. doi: 10.1002/art.37715. - DOI - PubMed
    1. Mohammad A.J. An Update on the Epidemiology of ANCA-Associated Vasculitis. Rheumatology. 2020;59((Suppl. S3)):42–50. doi: 10.1093/rheumatology/keaa089. - DOI - PubMed

LinkOut - more resources